ClinicalTrials.Veeva

Menu

A Real-time Quality Control System of Magnetic-controlled Capsule Gastroscopy

S

Shandong University

Status

Completed

Conditions

Magnet Controlled Capsule Endoscopy

Treatments

Other: AI-box

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT04954677
2021-SDU-QILU-087

Details and patient eligibility

About

With the rapid development of artificial intelligence technology, more and more deep learning technology has been applied to medicine. Our research is to develop a set of quality control system for magnetic capsule gastroscope using deep learning technology, and conduct a randomized controlled trial to verify its practical efficiency.

Full description

The accuracy of magnetic controlled capsule endoscopy(MCCE) in the diagnosis of stomach lesions is highly consistent with the traditional electronic gastroscopy. It has become a new comfortable and safe form for screening and It is also the beneficial complementarity of the traditional electronic gastroscope. To ensure the medical quality of magnetic controlled capsule endoscopy system, Based on Artificial Intelligence Deep Learning Technology ,investigators developed the Magnetic-controlled Capsule Endoscopic Assisted Quality Control System(AI-box).Randomized controlled trials will be conducted on prospective subjects to verify the quality control efficiency.

Enrollment

194 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Consecutive patients aged 18-75 years old who underwent MCCG examination in Qilu Hospital of Shandong University, Shandong Provincial Hospital affilated to Shandong First Medican University, and the Binzhou Medical University Hospital.

Exclusion criteria

  • People who are allergic to the ingredients prepared in the stomach before examination;
  • Patients with astrointestinal bleeding or ulcers, or prior gastrointestinal bleeding or ulcers within the last 24 months;
  • Patients with esophageal and gastric tumor diseases that are undergoing active surgical treatment;
  • Contraindications to the MCE test, including suspected or known gastrointestinal obstruction, stenosis, fistula, diverticula, etc; presence of gastrointestinal obstruction symptoms such as pain or dysphagia;
  • Prior gastrointestinal tract or abdominal surgery other than simple procedures which would not change the gastrointestinal tract anatomy, such as polyp removal, cholecystectomy or appendectomy;
  • Inoperative conditions or refusal to undergo abdominal surgery if required (ie, if the capsule will not pass and cannot be removed by endoscopy);
  • A cardiac pacemaker is installed in the body, except when the pacemaker is a new MRE-compatible product;
  • Electronic devices such as cochlear implant, magnetic metal drug infusion pump, nerve stimulator and magnetic metal foreign body are implanted in vivo;
  • Planned MRI examination before capsule endoscopy discharge;
  • Pregnant women;
  • Patients with deglutition disorders or gastric emptizing disorders.

Trial design

Primary purpose

Screening

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

194 participants in 2 patient groups

Participates being subjected to capsule endoscopy (AI-box assistant)
Experimental group
Description:
In this group ,Participates will be subjected to magnetically controlled capsule gastroscopy with AI-box assistant.
Treatment:
Other: AI-box
Participates being subjected to capsule endoscopy
No Intervention group
Description:
In this group ,Participates will be subjected to magnetically controlled capsule gastroscopy without AI-box assistant.

Trial contacts and locations

1

Loading...

Central trial contact

Dawei Shen, MD; Zhen Li, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems